This Week in PLoS

In PLoS One this week, investigators at McGill University report their use of exon-level transcriptome profiling in murine breast cancer, which revealed "splicing changes specific to tumors with different metastatic abilities." Specifically, in their statistical analysis the team found "significant expression changes in four percent of exons and one percent of intronic regions, affecting 2,263 out of 16,654 genes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.